Global Myopia and Presbyopia Treatment Industry to 2030 – Featuring AbbVie, Carl Zeiss and Nidek, among others – ResearchAndMarkets.com | Business and finance

DUBLIN–(BUSINESS WIRE)–April 27, 2022–

The Report “Myopia and Presbyopia Treatment Market Share, Size, Trends, Industry Analysis Report, By Myopia Treatment Type, By Presbyopia Treatment Type; By Region; Forecast segment, 2022-2030” has been added to ResearchAndMarkets.com’s offering.

According to a new study, the global myopia and presbyopia treatment market size is expected to reach USD 30.66 billion by 2030. The report provides a detailed overview of current market dynamics and provides growth analysis market future.

The increasing incidence of visual impairment coupled with the growing number of geriatric populations are the major factors likely to propel the demand for the industry across the globe. The increasing prevalence of visual impairment problems, along with the growing risks of pathological conditions associated with retinal damage, glaucoma, and cataracts are expected to drive the growth of the global industry.

Based on the type of myopia treatment, the corrective segment is dominating the global industry and is expected to lead the industry during the forecast period. Factors such as increasing prevalence of myopia in developing countries are contributing to the growth of the segment. The large pool of patients is attributed to the growing demand for corrective lenses among the population.

The growing geriatric population worldwide is expected to drive the growth of the industry. The geriatric population is more prone to vision loss, as most adults develop lifestyle-related vision disorders. For example, according to the United Nations, there will be 727 million people aged 65 or over worldwide in 2021. Additionally, the number of older people is expected to double to 1.5 billion by 2050.

Thus, this increasing incidence is a determining factor for the demand of the industry. Moreover, the growing number of ongoing researches and growing product pipeline globally are expected to boost the growth of the industry.

Market dynamics

Drivers and opportunities

  • Increased prevalence of eye disorders
  • Technological innovations

Constraints and challenges

The publisher has segmented the Myopia and Presbyopia Treatment market report based on Myopia Treatment Type, Presbyopia Treatment Type and Region:

Myopia and Presbyopia Treatment, Myopia Treatment Type Outlook (Revenue – USD Million, 2018 – 2030)

  • Patch
  • Corrective lenses
  • Alone
  • Bifocal
  • Trifocal
  • Contact lenses
  • Others
  • Surgical
  • Medications

Myopia and Presbyopia Treatment, Presbyopia Treatment Type Outlook (Revenue – USD Million, 2018 – 2030)

  • Corrective lenses
  • Reading glasses
  • Bifocal
  • Multifocal
  • Monovision
  • Modified Monovision
  • Contact lenses
  • Bifocal
  • Multifocal
  • Monovision
  • Modified Monovision
  • Intraocular lenses
  • refractive surgery

Myopia and Presbyopia Treatment, Regional Outlook (Revenue – USD Million, 2018 – 2030)

  • North America
  • WE
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East and Africa
  • United Arab Emirates
  • Saudi Arabia
  • Israel
  • South Africa

Companies cited

  • AbbVie
  • ALCON inc.
  • Alcon Vision LLC
  • Bausch & Lomb Incorporated
  • Bausch Health Companies Inc.
  • Carl Zeiss AG
  • Essilor ltd.
  • United Kingdom
  • Johnson & Johnson Vision
  • Nidek Company
  • Orasis Pharmaceuticals
  • Regeneron Pharmaceuticals Inc.
  • Sydnexis
  • Cooper Companies Inc.
  • Topcon Corporation
  • Zimmer Ophthalmic Systems SA

For more information about this report visit https://www.researchandmarkets.com/r/7mmmgj

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220427005817/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Officer

[email protected]

For EST business hours, call 1-917-300-0470

For US/CAN call toll free 1-800-526-8630

For GMT office hours call +353-1-416-8900

KEYWORD:

SECTOR KEYWORD: HEALTH OPTICS

SOURCE: Research and Markets

Copyright BusinessWire 2022.

PUBLISHED: 04/27/2022 11:23 AM/DISC: 04/27/2022 11:23 AM

http://www.businesswire.com/news/home/20220427005817/en

Copyright BusinessWire 2022.

Source link

About Chris Y. Camp

Check Also

George Michael paid for stranger’s ‘miracle’ IVF treatment

George Michael paid for the IVF treatment of a stranger, we learned. The music icon …